🌱 KidneyEnergy.com

← brief for 2026-08-10 · Slowing decline

Prevention of new-onset chronic kidney disease with renin–angiotensin system blockers in type 2 diabetes with preserved kidney function

Paper C Peer reviewed Observational

Key takeaways

In people with type 2 diabetes whose kidneys still worked normally, taking blood-pressure drugs called RAS blockers (ACE inhibitors or ARBs) was linked to fewer new cases of chronic kidney disease. This kind of study shows a link, not firm proof of cause. Still, it supports using these drugs early to protect kidneys.

Who did this work

Wan-Chia Hsu · Shih-Yuan Hung · Sheng‐Hsiang Lin · Yuan‐Yow Chiou · Yu‐Ling Lin · Hsi-Hao Wang · Li‐Chun Ho · Yi‐Che Lee

Source

Indexed paper · OpenAlex — CKD concept sweep (DB seed + weekly delta) · 2026-08-05
https://doi.org/10.6084/m9.figshare.33162027.v1